Peer-reviewedLicence not statedJAMA Dermatology
Targeted and Immune-Based Therapies in Cutaneous T-Cell Lymphomas
5 affiliations
- 1Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
- 2Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
- 3Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
- 4Division of Dermatology, Faculty of Medicine, University of Alberta, Edmonton, Alberta, Canada
- 5Division of Dermatology, Department of Medicine, Women’s College Hospital, Toronto, Ontario, Canada
Related
- Immune-cell depleted diffuse large B-cell lymphomas have reduced expression of MHC class I
- Editorial: Targeted therapies in gastric cancer: molecular signatures and immune microenvironment insights
- 1190 Spatial and phenotypic characterization of tertiary lymphoid structures and immune organization in cutaneous squamous cell carcinoma using multiplex immunofluorescence
- Overcoming adaptive resistance in non-small cell lung cancer: integrating targeted therapies, immunotherapy synergy, and nanocarrier delivery
- Navigating the landscape of targeted therapies for renal cell carcinoma in the era of precision medicine (Review)
BibTeX
@article{bai2026targeted,
title = {{Targeted and Immune-Based Therapies in Cutaneous T-Cell Lymphomas}},
author = {Jia Qi Adam Bai and Sherilyn Wen and Nicole Chu and Ryan S. Q. Geng and Robert Gniadecki and Vincent Piguet},
journal = {JAMA Dermatology},
year = {2026},
month = oct,
doi = {10.1001/jamadermatol.2026.4263},
url = {https://doi.org/10.1001/jamadermatol.2026.4263},
}
RIS
TY - JOUR
TI - Targeted and Immune-Based Therapies in Cutaneous T-Cell Lymphomas
AU - Jia Qi Adam Bai
AU - Sherilyn Wen
AU - Nicole Chu
AU - Ryan S. Q. Geng
AU - Robert Gniadecki
AU - Vincent Piguet
PY - 2026
DA - 2026/10/28
JO - JAMA Dermatology
DO - 10.1001/jamadermatol.2026.4263
UR - https://doi.org/10.1001/jamadermatol.2026.4263
SN - 2168-6068
SN - 2168-6084
ER -